ISEQ falls as Elan crashes again

The ISEQ index was down 10.68 points mid-morning at 6285.66.

It was another bad morning for Elan, as a report said that a fourth patient taking Tysabri, its multiple sclerosis drug, may have contracted a fatal brain disease. Shares in Elan fell €1.00 (15.9%) to €5.30.